Affymax, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2006-12-15. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The firm has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company’s product, OMONTYS.
AFFY stock price ended at $0 on Perşembe, after rising NaN%
On the latest trading day Jan 15, 2026, the stock price of AFFY rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 4.9K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 1.3K shares were traded, amounting to a market value of approximately --.
AFFYTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 0
Nötr Sinyaller 6
Satış Sinyalleri 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
AFFY, şu anda 0 alım sinyali ve 1 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Yukarı trend durumundadır ve bu dönemde toplam -- fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Sell görünüm işaret etmektedir.
AFFY için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek AFFY için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.
Takip Soruları
Teknik analiz göstergeleri AFFY için nasıl uygulanır?
AFFY için Fibonacci geri dönüş seviyeleri nelerdir?